A detailed history of Simplify Asset Management Inc. transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Simplify Asset Management Inc. holds 1,492,792 shares of ATHA stock, worth $865,819. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,492,792
Previous 1,492,792 -0.0%
Holding current value
$865,819
Previous $671,000 -0.0%
% of portfolio
0.04%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$2.36 - $3.59 $242,239 - $368,491
102,644 Added 7.38%
1,492,792 $4.4 Million
Q1 2023

May 10, 2023

BUY
$2.26 - $4.22 $3.14 Million - $5.87 Million
1,390,148 New
1,390,148 $3.48 Million

Others Institutions Holding ATHA

About Athira Pharma, Inc.


  • Ticker ATHA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,817,700
  • Market Cap $21.9M
  • Description
  • Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...
More about ATHA
Track This Portfolio

Track Simplify Asset Management Inc. Portfolio

Follow Simplify Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplify Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Simplify Asset Management Inc. with notifications on news.